FDA Indications for Use 510(k) K032471: Intended for adjunctive diagnostic screening for the detection of breast cancer and other uses
such as: peripheral vascular disease, neuromusculoskeletal disorders, extracranial cerebral facial vascular disease, thyroid gland
abnormalities, and various other neoplastic,metabolic, and inflammatory conditions.
Use of the TyTron C-500 is not intended to be a sole diagnostic procedure for these diseases and conditions.
*MOBILE PORTABLE UNITS AND ENTRY LEVEL SOLUTIONS AVAILABLE CLICK HERE TO VIEW CONFIGURATIONS*